Dark Report The Dark Report The Dark Report The Dark Report The Dark Report The Dark Report
About The Dark Report
Current Issue Archive Sample Copy Subscribe
shim
Home
shim
The Dark Report
shim
Executive War College
shim
Income Symposium
shim
Audiotapes
shim
Contact Us
The Dark Report
 

       Headlines - January 12, 2009
          Order Article PDF or Hardcopy / Become a Charter Member Today!

R. Lewis Dark: Primum non nocere, or: First, Do No Harm!

"FIRST, DO NO HARM!" IS KNOWN TO EVERY HEALTHCARE PROFESSIONAL. However, I was surprised to learn that this famous phrase is not from the Hippocratic Oath!

In checking wikipedia.com as I wrote the headline above, I learned that "the phrase expresses one of the principal precepts allmedical students are taught in medical school and is a fundamental principle for the emergencymedical services." Wikipedia has an interesting discussion of early references to this sentence and its use in medicine, but does note that, by around 1900, it was in common use within the medical community here in the United States.

I wanted to call your attention to this precept of "First, do no harm!" in the context of the disclosure by Quest Diagnostics Incorporated that it had, for 18 months during 2007 and 2008, reported inaccurate Vitamin 25(OH) D results to tens of thousands of patients and had instituted a voluntary notification and retest program for patients who had received inaccurate test results. In speaking to THE DARK REPORT (which was first to break this important story) and the national press, Quest Diagnostics is downplaying the potential negative consequences to patients. One Quest pathologist even told a reporter that he doubted that patients would have suffered any harm from the problem! A written Quest statement read on a television news broadcast declared that, following its notification campaign, "we have not been made aware of any adverse impact to patients."

I personally find this a disappointing public face to the problems created by the inaccurate test results Quest Diagnostics sent to patients and their physicians.

The New York Times reporter quoted one doctor who said, "There was a patient we put on vitamin D and all of a sudden, for the first time ever, the patient came back with what seemed to be a toxic level of vitamin D. "When the patient had his Vitamin D tested by another laboratory, the "value was considerably lower." On disease-specific bulletin boards and discussion groups, it is not difficult to find postings dating back two years by concerned patients who are upset by odd or discordant values on their Vitamin D tests performed by Quest.

By repeatedly stating "no harm to any patients (that we know of)," Quest shows a lack of respect for the turmoil it has caused to patients and physicians. Of course, lawyers have a hand in these public statements. Still, I come from the old-fashioned school of values, where admitting amistake is the right thing to do and the first step to rebuilding trust withmy customers andmy friends.



Inaccurate Results + Quest Dominates News Cycle

From the New York Times to CNN News, Quest's Inaccurate Vitamin D testing is a big story

CEO SUMMARY: Most laboratory professionals don't know it yet, but significant changes occurred to the entire lab industry last week. After Quest Diagnostics Incorporated acknowledged that it was retesting tens of thousands of patients because 7% of the Vitamin D results it reported during an 18-month period were inaccurate, a blitz of newspaper headlines and television news coverage of the story alerted Americans to the problem.




Labs Need to Respond To Inaccurate Results

In 2004, ongoing failures in HCV, HIV testing at a Baltimore hospital lab became national news

CEO SUMMARY: What does a lab do when it discovers that it has reported inaccurate test results? In 2004, a turnaround team arrived at the laboratory of Maryland General Hospital in Baltimore to deal with the consequences of a failed infectious disease testing program. For about two years, the lab had reported inaccurate HCV and HIV results. One member of that turnaround team shares lessons learned that pathologists can use to develop effective contingency plans for their own labs.



Dennis Monahan of ARUP Dies on Christmas Eve

He was ARUP's first sales representative and contributed to the lab's growth for 24 years



Lab Conserves Blood When Drawing Patients

Rhode Island hospital laboratory has lead role in encouraging adoption of transfusion-free medicine

CEO SUMMARY: New attention on both the risks associated with blood transfusions and the cost of blood products is triggering action by the nation's hospitals. At the 719-bed Rhode Island Hospital, the laboratory is on the front line of the hospital's blood management initiative. One change in longstanding practices is to encourage phlebotomists to draw only the minimum amount of blood required for lab testing. However, smaller specimens require changes to lab operations.



ASCP Awarded PEPFAR II Funds for Lab Assistance

ASCP members now serving 15 PEPFAR countries to help improve lab testing services

CEO SUMMARY: With new Congressional authorization and funding of $48 billion, PEPFAR II-a second five-year initiative to help targeted countries battle HIV, AIDs, tuberculosis, and malaria—is about to get under way. To better support diagnosis and management of HIV/AIDs patients, some PEPFAR funds are designated to expand laboratory testing services in countries with high prevalence rates of HIV/AIDS. ASCP's funding award will support laboratory training events and technical assistance to labs in 12 PEPFAR countries.


INTELLIGENCE: Late & Latent

DOUBLE-DIGIT GROWTH AGAIN AT BIO-REFERENCE

BIOIMAGENE SELLS 100 DIGITAL PATHOLOGY SYSTEMS

 

Copyright 2009 © DarkReport.com All rights reserved worldwide •